Physician profile
Jason E Mudd
NPI 1881879005
$9,068.89
in general payments reported to CMS, 2019-2025
20 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,815 · 2020: $168 · 2021: $932 · 2022: $950 · 2023: $2,123 · 2024: $683 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472 · Travel and Lodging: $1,698 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,471.92 |
| Travel and Lodging | $1,697.64 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,305.59 | 2022-2025 | Inspire |
| Intersect Ent, INC. | $2,083.03 | 2019-2020 | |
| Smith+Nephew, INC. | $1,574.12 | 2023 | Tula, Coblation |
| Medical Device Business Services, INC. | $917.29 | 2021 | |
| Medtronic USA, INC. | $687.14 | 2019 | |
| Genzyme Corporation | $251.55 | 2022-2025 | |
| Medtronic, INC. | $221.63 | 2021-2025 | Sinuva, Propel, Fusion |
| Glaxosmithkline, LLC. | $184.64 | 2023-2025 | Nucala |
| Optinose US, INC. | $179.03 | 2019-2024 | |
| Cochlear Americas | $149.61 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Aerin Medical INC. | $138.13 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $120.92 | 2025 | Tezspire |
| Zoll Respicardia, INC. | $67.69 | 2025 | Remede System |
| Acclarent, INC | $43.63 | 2022-2024 | Acclarent Aera |
| Amgen INC. | $34.00 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $31.66 | 2022-2023 | Integra, Integra Duo, Instruments-Orthopedic |
| Regeneron Healthcare Solutions, INC. | $27.03 | 2025 | Dupixent |
| Itamar Medical INC | $21.04 | 2024 | Watchpatone |
| Olympus America INC. | $16.20 | 2024 | Rhino-Laryngo Videoscope |
| Covidien Lp | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Mudd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.